Anuncio
Anuncio
CNSP
CNS Pharmaceuticals, Inc. Common Stock
6.05
USDPatrocinado
+0.11
+1.94%
09 ene, 15:59 UTC -5
Cerrado
Post-mercado
6.05
-0.01
-0.15%
Informes de beneficios de CNSP
Ratio de Sorpresa Positivo
CNSP superó 7 de las últimas 17 estimaciones.
41%
Próximo informe
Fecha del próximo informe
30 mar 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$5.83
Cambio implícito desde Q3 25 (Revenue/ EPS)
--
/+1.22%
Cambio implícito desde Q4 24 (Revenue/ EPS)
--
/-94.75%
CNS Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On 14 nov 2025, CNSP reported earnings of -5.76 USD per share (EPS) for Q3 25, beating the estimate of -7.23 USD, resulting in a 20.41% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.90% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -5.83 USD, with revenue projected to reach -- USD, implying an aumentar of 1.22% EPS, and aumentar of 0.00% in Revenue from the last quarter.
Preguntas frecuentes
What were CNS Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, CNS Pharmaceuticals, Inc. Common Stock reported EPS of -$5.76, beating estimates by 20.41%, and revenue of $0.00, 0% as expectations.
How did the market react to CNS Pharmaceuticals, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.9%, changed from $6.90 before the earnings release to $6.70 the day after.
When is CNS Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30 mar 2026.
What are the forecasts for CNS Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on 4
analistas, CNS Pharmaceuticals, Inc. Common Stock is expected to report EPS of -$5.83 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Cheque FXEmpire's Earnings Calendar for today's list of reporting companies.
Anuncio